NeoDynamics has introduced its new precision biopsy system, NeoNavia® for ultrasound-guided breast biopsies.
Advances in breast cancer screening, imaging, and breast cancer treatments have created new demands for developing new technologies for tissue sampling in breasts and axillary lymph nodes.
An innovative biopsy system
NeoNavia is an innovative biopsy system built on a patented pulse technology for controlled and precise needle insertion and is based on research at the Karolinska Institutet in Sweden. The system was developed by NeoDynamics AB and is now being commercially introduced into the first markets.
READ MORE: NeoNavia
Patented pulse technology developed at the Karolinska Institute
Control & precision during needle insertion
Stabilisation of the lesion during tissue sampling
FlexiPulse gave 299% higher tissue yield than a standard 14G CNB
Maintain control throughout the procedure
Less tissue deformation compared to standard devices